Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity Apr 23, 2012 01:21PM
Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through Apr 19, 2012 03:17PM
Brean Murray Carret & Co. Maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Becoming Top Hec C Play Apr 5, 2012 09:36AM
Brean Murray Adds Achillion (ACHN), Pitney Bowes (PBI), Vivus (VVUS) to 'Focus List'; Removes Gilead (GILD) Apr 2, 2012 09:13AM
Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile Jan 10, 2012 02:57PM

Jun 2, 2011 09:59AM Brean Murray Carret & Co. Starts Achillion Pharmaceuticals (ACHN) at Buy, $9 Pirce Target